My answer to Amatuer17's FUD about Phase 3 taking
Post# of 72435
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
Quote:
Since you like to compare things,
Oritavancin Phase 2 completion date: May 2008
https://clinicaltrials.gov/ct2/show/NCT005145...amp;rank=1
Oritavancin Phase 3 start date: December 2010
https://clinicaltrials.gov/ct2/show/NCT012527...amp;rank=1
SPA application date: March 26, 2010
http://www.accessdata.fda.gov/drugsatfda_docs...00MedR.pdf
SPA agreement date: November 30, 2010
http://www.firstwordpharma.com/node/809053#axzz4ABcs9svI
Both Oritavancin and Brilacidin are single-dose treatment for ABSSSI with QIDP designation.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)